874974-99-9

Upstream product

• 874974-98-8 [4-chloro-3-(3-bromo-5-chloro-phenoxy)-2-fluoro-phenyl]-acetic acid ethyl ester 
• 33863-76-2 1-bromo-3-chloro-5-fluorobenzene 
• 174913-12-3 1-bromo-3-chloro-5-methoxybenzene 
• 56962-04-0 3-bromo-5-chlorophenol 
• 874974-96-6 [3-(3-bromo-5-chloro-phenoxy)-2-fluoro-4-nitro-phenyl]-acetic acid ethyl ester 
• 874974-97-7 [4-amino-3-(3-bromo-5-chloro-phenoxy)-2-fluoro-phenyl]-acetic acid ethyl ester 
• 1093267-98-1 2-[(3-bromo-5-chlorophenyl)oxy]-3,4-difluoro-1-nitrobenzene 
• 1093987-88-2 1,1-dimethylethyl ethyl {3-[(3-bromo-5-chlorophenyl)oxy]-2-fluoro-4-nitrophenyl}propanedioate 

Downstream Products

• 874975-00-5 C₁₆H₁₃BrCl₂FN₃O₃ 
• 1094347-65-5 2-({3-[(3-bromo-5-chlorophenyl)oxy]-4-chloro-2-fluorophenyl}methyl)-5-(3,5-dimethyl-4-isoxazolyl)-1,3,4-oxadiazole 
• 1094345-69-3 3-[5-({3-[(3-bromo-5-chlorophenyl)oxy]-4-chloro-2-fluorophenyl}methyl)-1,3,4-oxadiazol-2-yl]pyridine 
• 1094345-66-0 4-[5-({3-[(3-bromo-5-chlorophenyl)oxy]-4-chloro-2-fluorophenyl}methyl)-1,3,4-oxadiazol-2-yl]pyridine 
• 1094347-67-7 3-chloro-5-[(6-chloro-3-{[5-(3,5-dimethyl-4-isoxazolyl)-1,3,4-oxadiazol-2-yl]methyl}-2-fluorophenyl)oxy]benzaldehyde 
• 1094345-37-5 (2E)-3-{3-chloro-5-[(6-chloro-3-{[5-(3,5-dimethyl-4-isoxazolyl)-1,3,4-oxadiazol-2-yl]methyl}-2-fluorophenyl)oxy]phenyl}-2-propenenitrile 
• 1094341-69-1 3-chloro-5-[(6-chloro-2-fluoro-3-{[5-(4-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl}phenyl)oxy]benzonitrile 
• 1094341-70-4 3-chloro-5-[(6-chloro-2-fluoro-3-{[5-(3-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl}phenyl)oxy]benzonitrile 
• 1093988-11-4 3-[5-({3-[(3-bromo-5-chlorophenyl)oxy]-4-chloro-2-fluorophenyl}methyl)-1,3,4-oxadiazol-2-yl]-N,N-dimethylaniline 
• 1093987-99-5 N'-({3-[(3-bromo-5-chlorophenyl)oxy]-4-chloro-2-fluorophenyl}acetyl)-3-cyanobenzohydrazide 
• 1093987-95-1 N'-({3-[(3-bromo-5-chlorophenyl)oxy]-4-chloro-2-fluorophenyl}acetyl)-4-(methyloxy)benzohydrazide 
• 1093987-91-7 N'-({3-[(3-bromo-5-chlorophenyl)oxy]-4-chloro-2-fluorophenyl}acetyl)-3-(methyloxy)benzohydrazide 
• 1093988-07-8 2-({3-[(3-bromo-5-chlorophenyl)oxy]-4-chloro-2-fluorophenyl}methyl)-5-[2-fluoro-3-(methyloxy)phenyl]-1,3,4-oxadiazole 
• 1093988-02-3 4-{[2-({3-[(3-bromo-5-chlorophenyl)oxy]-4-chloro-2-fluorophenyl}acetyl)hydrazino]carbonyl}-N,N-diethylbenzenesulfonamide 

Relevant academic research and scientific papers

CHEMICAL COMPOUNDS

The present invention relates to compounds that are a non-nucleoside reverse transcriptase inhibitors, and to processes for the preparation and use of the same. Specifically, the present invention includes methods of using such compounds in the treatment of human immunodeficiency virus infection.

CHEMICAL COMPOUNDS

The present invention relates to compounds that are a non-nucleoside reverse transcriptase inhibitors, and to processes for the preparation and use of the same. Specifically, the present invention includes methods of using such compounds in the treatment of human immunodeficiency virus infection.

Heterocyclic antiviral compounds

The present invention relates to a compounds according to formula I, methods for treating diseases mediated by human immunodeficieny virus by administration of a compound according to formula I and pharmaceutical compositions for treating diseases mediated by human immunodeficieny virus containing a compound according to formula I where R1, R2, R3, R4, R5, are as defined herein.